Ellison scraps $7.5B Oracle stock sale plan amid European regulatory scrutiny

Larry Ellison announced a stock sale plan on a Friday and scrapped it by Saturday. The Oracle co-founder had disclosed a Rule 10b5-1 trading arrangement that would have permitted him to sell up to 50 million shares of the company he helped build, a position worth roughly $7.5 billion at current prices. No shares changed hands under the plan before he cancelled it, and Oracle's official statement made clear he has no intention to sell Oracle stock through any other mechanism either.

The speed of the reversal points to a collision between two regulatory systems. In the United States, executives can establish these pre-arranged trading plans during periods when they possess material, non-public information—say, just before earnings are announced. The SEC allows it because the plan was locked in beforehand, creating a legal shield against accusations of insider trading. The rule, formalized in 2000 and tightened in 2022, requires public disclosure of the plan's existence, which is why Ellison's arrangement became known at all. Europe operates on a different principle. Under the Market Abuse Regulation, company insiders cannot trade shares during the 30 calendar days immediately before a financial report is released. There is no safe harbour for pre-arranged sales. The trading window simply closes. European regulators focus on reporting completed transactions rather than flagging intentions, and only when cumulative sales cross the €5,000 threshold.

Ellison's plan landed in a sensitive moment. Oracle had just reported earnings that mixed genuine strength with visible strain. Cloud infrastructure revenue jumped 121 percent year-over-year, beating analyst expectations. But gross margins contracted, and the company raised its estimate for restructuring costs to $2.8 billion. The stock fell 1.7 percent on the news. Over the full year, Oracle shares have declined roughly 20 percent as the company has taken on substantial debt to fund its infrastructure expansion.

The timing of the sale announcement—coming a day after results—created an awkward optics problem. Ellison controls approximately 40 percent of Oracle and serves as executive chair and chief technology officer. Selling 50 million shares would have been extraordinary by his own historical standard. According to FactSet data, he has not sold more than 25,000 shares at a time since 2000. Even after offloading 50 million shares, he would have retained roughly 1.1 billion shares, maintaining overwhelming control. Still, the sheer volume of the proposed transaction, combined with the company's recent disclosure of margin pressure and elevated restructuring expenses, created a narrative risk that European regulators would have flagged as problematic.

The cancellation reveals how multinational technology companies navigate divergent rule sets. An American executive can use a 10b5-1 plan to execute a predetermined strategy during periods when trading would otherwise invite scrutiny. A European executive faces a hard stop. For a company like Oracle, which operates globally and whose leadership must answer to both SEC and EU regulators, the safer path is often to defer to the more restrictive regime. Ellison's decision to abandon the plan after a single day suggests that the European regulatory environment—or the reputational risk of appearing to circumvent it—outweighed the benefits of executing a sale that was technically permissible under American law.